Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
David Sarid
38 years of experience
accreditations :
Clinic is certified :
Immunotherapy for prostate cancer in Israel typically costs from $14,000 to $26,000. The final price depends on the drug protocol, number of cycles, and necessary diagnostic imaging like PET/CT scans. In the US, similar procedures cost around $76,500 on average. Patients save around 74% compared to the US. Most Israeli hospitals include the initial specialist consultation and treatment monitoring in their oncology service fees.
Bookimed Expert Insight: Choosing a multidisciplinary center like Sourasky Medical Center (Ichilov) provides access to elite experts like Dr. Ofer Merimsky. Sourasky reports a 90% average success rate for oncology treatments. While Assuta offers private care starting around $2,500, larger centers provide comprehensive research-backed protocols. Patients benefit from JCI-accredited facilities and doctors with extensive international training from US and European institutions.
Why choose Israel for immunotherapy for prostate cancer?
Access advanced immunotherapy for prostate cancer solutions in trusted clinics from $14,000.
| Israel | Turkey | Austria | |
| Immunotherapy for prostate cancer | ≈ $14,000 | from $8,000 | ≈ $30,000 |
Day 1
Day 2
Day 3
Day 4
Week 1
Week 2
Week 3
Week 4
Please note that each patient"s experience with Immunotherapy for prostate cancer can vary. The above timeline provides a general guideline but individual cases may differ.
What patients like:
What patients don’t like:
As the leading global medical tourism platform, Bookimed.com takes huge responsibility for providing reliable information to both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there. Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a leader in immunotherapy for prostate cancer.
Dr. Sarid specializes in prostate cancer immunotherapy at Sourasky Medical Center, with extensive training in cancer urology from Oxford University.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.
Prostate cancer immunotherapy in Israel focuses on immune checkpoint inhibitors like Keytruda and personalized cell-based vaccines such as Provenge. Top facilities deliver these alongside advanced diagnostics to target metastatic castration-resistant prostate cancer and neuroendocrine differentiation in JCI-accredited centers.
Bookimed Expert Insight: Israeli oncology centers often integrate immunotherapy with precision radiation, such as the Novalis TrueBeam STx technology. Expert practitioners like Dr. Yaacov Lawrence at Sheba Medical Center specialize in these combinations, which may enhance immune response compared to using drug-based immunotherapy alone.
Patient Consensus: Patients emphasize verifying tumor MSI-high status before travel to ensure eligibility for Keytruda. Consensus suggests being cautious of unproven vaccine offers and sticking to major centers for verified clinical trials.
Candidates for prostate cancer immunotherapy include patients with advanced, metastatic, or recurrent disease who have not responded to hormone therapy. Eligibility depends on genetic markers like microsatellite instability-high (MSI-H), mismatch-repair deficiency (dMMR), or high tumor mutational burden (TMB) found through genomic testing.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center treat over 40,000 cancer patients annually, creating a high-volume environment for identifying rare immunotherapy candidates. While many prostate cancers are immune-cold, experts like Dr. Ofer Merimsky utilize precision genomic testing to find the 2% to 3% of patients who may actually benefit from these targeted drugs.
Patient Consensus: Patients emphasize the necessity of formal genomic testing for MSI-high status before traveling, as most prostate cancers remain resistant to standard immunotherapy. Many view this treatment as a vital last-resort option after hormone and chemotherapy have stopped working.
Immunotherapy for prostate cancer primarily causes fatigue, skin reactions, and flu-like symptoms by triggering the immune system to attack healthy tissues. Common reactions include persistent exhaustion, rashes, and digestive issues. Serious complications may include organ inflammation affecting the liver, lungs, or colon if not managed promptly.
Bookimed Expert Insight: While many patients expect standard side effects, our data shows that Israeli centers like Sourasky Medical Center prioritize biomarker testing to predict tolerance. Clinics utilizing Foundation One CDx genetic testing can better identify if a patient is at higher risk for severe immune-related adverse events. This precision approach helps specialists like Dr. David Sarid manage toxicity before it becomes life-threatening.
Patient Consensus: Many patients describe the fatigue as more intense than expected, often requiring significant rest. Those on combination therapies like Opdivo and Yervoy report much tougher recovery periods compared to single-drug regimens.
Immunotherapy for prostate cancer trains the immune system to identify and destroy malignant cells, offering a vital alternative for advanced, treatment-resistant cases. Key benefits include extended survival, lower systemic toxicity compared to chemotherapy, and personalized treatment based on specific genetic markers like microsatellite instability.
Bookimed Expert Insight: Israel excels in transforming immune-cold prostate tumors through advanced combination protocols. Clinics like Sourasky Medical Center (Ichilov) utilize Foundation One CDx genetic testing to identify rare biomarkers. This confirms eligibility for specific agents that might be overlooked in standard diagnostic settings.
Patient Consensus: Many patients appreciate that immunotherapy preserves their quality of life. They find the treatment process significantly less exhausting than hormonal or chemical alternatives.
Lutetium-177 PSMA therapy targets metastatic castration-resistant prostate cancer by delivering localized radiation directly to malignant cells. This advanced radioligand treatment is available in Israel at JCI-accredited institutions like Sourasky Medical Center and Sheba Medical Center, which specialize in precision nuclear medicine and oncology.
Bookimed Expert Insight: Israeli medical centers often integrate genetic testing like Foundation One CDx alongside radioligand therapy. This combined approach allows surgeons at Sourasky Medical Center to verify if Lutetium-177 or alternatives like Actinium-225 are more effective for a patient’s specific mutation. This dual-layer mapping is a major reason why local oncology clinics manage over 40,000 cancer cases annually.
Patient Consensus: Patients emphasize the importance of monitoring for dry mouth after infusions. Most value the speed of the 10-minute treatment sessions compared to traditional chemotherapy protocols.
Patients receive immunotherapy for prostate cancer in Israel at top JCI-accredited facilities like Sourasky Medical Center (Ichilov), Sheba Medical Center, and Assuta Medical Center. These institutions utilize advanced checkpoint inhibitors like Keytruda (Pembrolizumab) and offer innovative clinical trials for metastatic cases under board-certified oncology specialists.
Bookimed Expert Insight: Israeli oncology centers often provide specific advantages for international patients that price-matched clinics elsewhere miss. For example, Sourasky Medical Center includes free interpreters and airport transfers. This clinical support eases the pathway for patients accessing complex Keytruda regimens or clinical trials at institutional leaders.
Patient Consensus: Many families emphasize verifying clinical trials through official registries as immunotherapy remains primarily experimental for prostate cancer. Patients recommend focusing on major research hospitals like Sheba or Sourasky for evidence-based treatments over unverified private clinic claims.
Immunotherapy for prostate cancer is administered through systemic IV infusions or localized intratumoral injections depending on the drug type. Treatments like Keytruda or Opdivo require outpatient infusions every 2 to 6 weeks. Specialized vaccines like Sipuleucel-T involve extracting and re-infusing immune cells after laboratory training.
Bookimed Expert Insight: While IV infusions are standard, Israeli centers like Sourasky often offer localized intratumoral injections through experimental protocols. This method acts like an internal vaccine. It may reduce systemic side effects like colitis by focusing the immune response directly within the tumor site.
Patient Consensus: Many patients find localized injections safer than systemic IV treatment. They emphasize checking enrollment for international trials at major centers like Sheba or Sourasky if standard therapies fail.
Israel is a premier neurosurgery hub due to its fusion of high-density medical innovation and elite surgical expertise. Top facilities like Sheba Medical Center integrate AI-guided navigation and real-time intraoperative MRI. Specialized centers report 98% success rates for complex procedures including awake craniotomy and movement disorder treatments.
Bookimed Expert Insight: Data shows a clear divide between public and private options in Israel. Private centers like Assuta Medical Center perform over 92,000 operations annually and allow patients to select their specific lead surgeon. This is a vital advantage for complex cases where a specific expert like Dr. Eli Ashkenazi is preferred for his 1,000+ spine surgery record.
Patient Consensus: Patients emphasize bringing original imaging on a USB for local review to streamline the surgical plan. They also note that private packages often include hotel coordination and airport transfers, making the logistics much smoother.
Israeli neurosurgeons treat a full spectrum of conditions ranging from brain and spinal tumors to complex functional disorders. Specialized centers utilize advanced technologies like Gamma Knife, deep brain stimulation, and intraoperative MRI to manage epilepsy, Parkinson disease, and cerebrovascular pathologies with high precision.
Bookimed Expert Insight: Israeli hospitals often combine specialties to handle complex cases. At Sourasky Medical Center, neurosurgeons like Dr. Zvi Lidar bridge neurosurgery and orthopedics for spinal care. This multidisciplinary approach allows clinics to perform 34,000+ operations annually. Choosing a facility with this crossover expertise often leads to more comprehensive treatment plans for degenerative diseases.
Patient Consensus: Patients value the ability to access specialized treatments like fluorescence-guided surgery for tumors which are often unavailable elsewhere. Many note that the staff is fluent in English and provides clear communication through teleconsultations before traveling.
Israel is home to world-renowned neurosurgery centers like Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These facilities are globally ranked for treating complex brain tumors, spinal disorders, and movement diseases. They utilize advanced technologies like Gamma Knife, robotic systems, and intra-operative MRI.
Bookimed Expert Insight: Our data shows that while most patients focus on Tel Aviv, Rambam Medical Center in Haifa offers unique expertise in neuro-trauma. It operates a specialized neuro-ICU and serves nearly 1 million patients annually. This makes it an essential choice for complex post-trauma brain surgeries that requires intensive recovery support.
Patient Consensus: Patients note it is important to start consultations early. They often highlight that the precision and follow-up care for complex brain tumors exceeded their expectations. One patient emphasized how quickly they could connect with top professors for second opinions during critical neurosurgical cases.
Israel's leading neurosurgeons include Prof. Zvi Ram, Prof. Shlomi Constantini, and Prof. Itzhak Fried at Sourasky Medical Center. These specialists hold leadership roles in the European Association of Neurosurgical Societies (EANS) and the World Society for Stereotactic and Functional Neurosurgery (WSSFN). They utilize advanced intraoperative mapping and robotic systems.
Bookimed Expert Insight: Data from Sourasky and Sheba indicates a strong correlation between high surgical volumes and patient safety. For example, Sourasky performs 34,000+ operations annually with a 90% oncology success rate. Patients seeking complex tumor removals should prioritize centers like these where surgeons perform hundreds of specific cases each year.
Patient Consensus: Patients emphasize the importance of finding a surgeon who specializes specifically in your condition rather than a generalist. Many note that high-volume centers provide better access to English-speaking staff and coordinated care for international visitors.
International neurosurgery patients in Israel must provide comprehensive medical records including recent MRI or CT scans translated into English. Admission requires a clinical review by specialists to confirm treatment feasibility. Hospitals often mandate full advance payment or a significant deposit before confirming surgery dates or issuing visa support letters.
Bookimed Expert Insight: Data shows that top Israeli facilities like Sheba Medical Center and Hadassah Medical Center handle massive patient volumes, exceeding 1,000,000 people annually. This high demand means clinics prioritize complex or rare cases over routine procedures. Patients with unique or high-risk conditions often receive faster admission approval than those seeking standard treatments available elsewhere.
Patient Consensus: Patients note that having all imaging results ready in English is essential for quick scheduling. Many emphasize that while the medical care is excellent, coordinating around Shabbat closures is necessary to avoid unexpected diagnostic delays.
A standard stay for neurosurgery in Israel ranges from 10 to 14 days for uncomplicated cases. Patients undergoing complex procedures like brain tumor removal or deep brain stimulation often require 4 to 6 weeks. This timeline covers pre-operative diagnostics, the surgical procedure, and essential post-operative monitoring.
Bookimed Expert Insight: Data from Sourasky Medical Center shows they treat over 400,000 patients annually with high success rates. Clinics with such high volumes, like Hadassah or Assuta, often have streamlined discharge protocols. This helps international patients transition to hotel-based recovery faster while maintaining access to top specialists.
Patient Consensus: Patients note it is vital not to rush home too early. Some travelers extended their stay to 3 weeks due to swelling or to ensure they received final surgeon clearance before flying.
Israeli neurosurgery uses robotic guidance, real-time 3D imaging, and incisionless technologies to minimize physical trauma. Systems like Mazor Robotics provide sub-millimeter precision for spine implants. MRI-guided focused ultrasound (MRgFUS) treats tremors without incisions. These advanced tools ensure high accuracy and reduce recovery times.
Bookimed Expert Insight: Israeli clinics like Sourasky or Hadassah integrate proprietary Israeli-born technologies like Surgical Theater before they hit global markets. Our data shows these centers often use VR flight-through models for pre-surgical planning. This allows surgeons to rehearse complex cases, which is a key factor in their 90% success rates.
Patient Consensus: Patients note that technologies like the Gamma Knife allowed them to return home in days rather than weeks. Many move from traditional 10cm incisions to cuts under 2cm when using robotic-assisted systems.
Israel is a global leader in neurosurgery due to its integration of proprietary medical innovations and internationally trained specialists. High-capacity centers like Sourasky Medical Center (Ichilov) perform over 34,000 annual surgeries. Patients access advanced techniques like awake craniotomy and MR-guided focused ultrasound.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of dually certified experts. Many top surgeons, such as Dr. Zvi Lidar, are certified to practice in both Israel and the USA. This ensures that patients receive American-standard surgical care while staying in Tel Aviv or Jerusalem. Our data shows that private centers like Assuta offer significantly faster access to these specific specialists compared to the public system.
Patient Consensus: Patients note it is important to confirm a surgeon's specific volume of cases for your exact condition. They also value the ability to get expert second opinions quickly through online consultations with world-renowned professors.
Sheba Medical Center and Sourasky Medical Center (Ichilov) are among the best neurosurgery hospitals in Israel. These JCI-accredited facilities perform thousands of operations annually. They utilize advanced technologies like CyberKnife and intraoperative MRI to treat complex brain tumors and cerebrovascular lesions.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah perform over 40,000 total operations yearly. This high volume allows surgeons to maintain a 90% success rate even in complex oncology cases. Patients seeking robotic spine surgery or deep brain stimulation should focus on these high-capacity municipal centers for the most experienced teams.
Patient Consensus: Patients appreciate that some hospitals quickly coordinate consultations even during regional strikes. Families of pediatric patients especially value surgeons trained at prestigious international institutions.
Israel's leading neurosurgeons include Professor Zvi Ram, Professor Shlomi Constantini, and Professor Itzhak Fried at Sourasky Medical Center. These experts specialize in awake craniotomy, pediatric brain tumors, and functional mapping. Most hold JCI accreditation and international fellowships from institutions like Johns Hopkins and Yale.
Bookimed Expert Insight: Data shows that top-tier Israeli neurosurgeons, such as those at Sourasky Medical Center, often hold dual board certifications in Israel and the US. This unique crossover ensures patients receive American-standard protocols. These specialists typically manage over 34,000 annual operations, providing high-volume clinical experience that smaller private clinics cannot match.
Patient Consensus: Patients note that highly qualified doctors like Professor Shlomo Constantini provide satisfactory answers quickly. People emphasize that outcomes often depend on the hospital’s integrated resources rather than just a doctor's prestige.
Israel is a global leader in neurosurgery, treating complex brain and spinal conditions using robotic-assisted and minimally invasive techniques. Highly specialized units at JCI-accredited centers like Sourasky Medical Center (Ichilov) and Hadassah Medical Center focus on neuro-oncology, pediatric neurosurgery, and functional procedures.
Bookimed Expert Insight: Israeli neurosurgical departments often function as rapid-response hubs for international patients. Data shows that large centers like Sourasky, which serves 1,800,000 patients annually, can organize expert video consultations in a very short time. This speed is critical for neuro-oncology cases where starting treatment a few days earlier significantly impacts outcomes.
Patient Consensus: Patients note that Israeli teams often accept high-risk cases that other hospitals decline. They emphasize the importance of using local coordinators to manage travel logistics or potential local disruptions during their two-week stay.
International patients traveling to Israel for neurosurgery require a valid passport, an entry permit or medical visa, and a formal hospital invitation. You must provide recent MRI or CT scans in DICOM format and detailed medical summaries. Proof of private health insurance and financial stability are also mandatory for border entry.
Bookimed Expert Insight: Our data shows that top neurosurgeons at Hadassah Medical Center and Sourasky often request records 4–6 weeks before arrival. Submitting these early prevents appointment shifts. High-volume centers with over 30,000 annual operations have dedicated portals for secure DICOM file uploads. Using these ensures your surgeon reviews high-quality images before you land in Tel Aviv.
Patient Consensus: Patients emphasize bringing physical copies and digital backups of all scans on a USB drive. They also note that private insurance needs pre-authorization specifically for neurosurgery to avoid payment delays at the clinic.